Meeting Coverage

  • Former ARP Presidents Analyze Successes and Challenges of the Past to Build for the Future

    Former ARP Presidents Analyze Successes and Challenges of the Past to Build for the Future

    Donning small plastic sprouts symbolizing optimism and a spirit of growth, former ARP presidents, including Teresa Brady, PhD, MACR, led a session highlighting achievements among rheumatology professionals and within the ARP over the past 35 years as a way of putting into perspective the current…

  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases

    FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases

    The U.S. Food and Drug Administration approved indications for adult and pediatric rheumatology as well as new biosimilars and interchangeables for the treatment of rheumatic disease. Erick J. Gapud, MD, PhD, provided an overview of these drugs.

  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice

    Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice

    Michael Pfeffer, MD, FACP, discussed his experience piloting technology that utilizes artificial intelligence to listen to real-time conversations between healthcare providers and patients, transcribing the dialogue into text that can become a patient note.

  • Speakers Explain How to Use Performance Measures for Hip, Knee OA Research and Care

    Speakers Explain How to Use Performance Measures for Hip, Knee OA Research and Care

    Performance-based tests and patient-reported outcome measures should be used in conjunction for the most comprehensive assessment of patient function and changes in function over time. Experts including Christine A. Pellegrini, PhD, discussed the advantages and shortcoming of these tools.

  • Session to Highlight Emerging Pathways in Immune-Induced Exaggerated Pain

    Session to Highlight Emerging Pathways in Immune-Induced Exaggerated Pain

    Dana Orange, MD, will discuss the disconnect she has observed between the level of pain and the amount of inflammation seen in the joints of patients with rheumatoid arthritis. Additional topics include calcium signaling in neuropathic pain and novel peptide Kv1.3 channel blockers.

  • Pediatric Rheumatology Meets Friendly Competition with Game-Based Learning

    Pediatric Rheumatology Meets Friendly Competition with Game-Based Learning

    New to the ACR Convergence lineup, the online game platform Kahoot! will challenge attendees’ knowledge of caring for young patients with rheumatic disease. The trivia-style competition will take place in real time during the session and requires a device that can connect to the internet.

  • Physician-Researchers Will Explore Emerging Advances in the Understanding of Pediatric ANCA-Associated Vasculitis

    Physician-Researchers Will Explore Emerging Advances in the Understanding of Pediatric ANCA-Associated Vasculitis

    Much of what is known about antineutrophil cytoplasmic antibody-associated vasculitis in children has been extrapolated from adult studies. Kimberly Morishita, MD, will outline ongoing research looking at organ-specific outcomes in pediatric patients with this disease.

  • Panel to Explain How Biomaterials Can Revolutionize the Development of Therapies for Autoimmune Diseases

    Panel to Explain How Biomaterials Can Revolutionize the Development of Therapies for Autoimmune Diseases

    Investigators are working to reprogram immune cells, specifically T-cells and antigen-presenting cells, at the site of disease to enhance their immunoregulatory potential. Nisarg Shah, PhD, will share progress on this front.

  • Session Will Highlight Intersection of Cellular Aging, Age-Related Inflammation, and Autoimmune Dysfunction

    Session Will Highlight Intersection of Cellular Aging, Age-Related Inflammation, and Autoimmune Dysfunction

    James Kirkland, MD, MSc, PhD, and other panelists will explain how inflammaging — chronic, low-grade, aging-related inflammation — is linked to age-related disorders, immune dysfunction, and autoimmunity-mediated disorders.